Please login to the form below
antimicrobial
This page shows the latest antimicrobial news and features for those working in and with pharma, biotech and healthcare.
UK selects Shionogi’s Fetcroja for antimicrobial reimbursement scheme
In the UK, over 5, 000 deaths per year are attributed to antimicrobial resistance (AMR), with over 25, 000 deaths per year attributed to AMR in the EU. ... AMR is a major health burden wherein bacteria, fungi, viruses and parasites become resistant to a
Latest news
-
MSD launches antibiotic combo Recarbrio in UK
Despite the urgent need for new therapeutics to tackle the growing incidence of antimicrobial resistance (AMR), few pharmaceutical companies are undertaking research in this area.
-
Shionogi’s novel antibiotic trial data published in The Lancet
In the UK, over 5, 000 deaths per year are attributed to antimicrobial resistance (AMR), with over 25, 000 death per year attributed to AMR in the EU. ... AMR is a major health burden wherein bacteria, fungi, viruses and parasites become resistant to a
-
Shionogi's Gram-negative antibiotic launches in the UK
In the UK, over 5, 000 deaths per year are attributed to antimicrobial resistance (AMR), with over 25, 000 deaths per year attributed to AMR in the EU. ... AMR is a major health burden wherein bacteria, fungi, viruses and parasites become resistant to a
-
Novartis’ Sandoz division announces antibiotic manufacturing plan
Earlier this month, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) raised nearly $1bn to support clinical research into new antibiotics in a bid to tackle growing antimicrobial resistance (AMR).
-
IFPMA launches AMR Action Fund to tackle antimicrobial resistance
a bid to tackle growing antimicrobial resistance (AMR). ... is a part of the broader issue of antimicrobial resistance.
More from news
Approximately 46 fully matching, plus 71 partially matching documents found.
Latest Intelligence
-
Rebranding in an evolving world
in recent years, despite the ever- increasing health burden of antimicrobial resistance globally.
-
Rethinking our approach to infectious disease preparedness
Antimicrobial resistance. There is a second pandemic that we have to deal with – the rising tide of antimicrobial resistance, where bacteria are becoming resistant to the antibiotics we routinely use to
-
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19. ... The World Health Organization (WHO) states that antimicrobial resistance (AMR) is a global concern.
-
The global antibiotic crisis: a 2020 perspective
In the forward of the 2019 CDC report on the threat posed by antimicrobial resistance he said simply: ‘We need stop referring to a coming post-antibiotic era – it’s already ... The plan is the latest step towards the government’s broader 20-year
-
The role of women in science and technology
Then there’s Victoria Savage, head of biology at the Antimicrobial Resistance Centre, which is the UK’s only dedicated R&D facility for this critically important field of work.
More from intelligence
Approximately 7 fully matching, plus 15 partially matching documents found.
Latest appointments
-
IFPMA names new communications director
and to enable government to meet ambitious goals such as universal health coverage, global health security and continued innovation in areas of high unmet health needs such as antimicrobial resistance.
-
Destiny Pharma appoints new CEO
Destiny Pharma has appointed Neil Clark as CEO as the Brighton, UK-based firm plans a phase IIb trial for its lead antimicrobial candidate.
-
New health ministers and re-appointments after reshuffle
Ellison, who reprises her role as the secretary for public health that she has held since 2013, also has a wide remit that includes pharma as will have responsibility for: antimicrobial
-
Xellia forms scientific advisory board
drugs to help tackle the global crisis of antimicrobial resistance.”. ... Antimicrobial resistance is a huge area of unmet medical need and one of the greatest threats to human health.
-
Cubist picks Robert Perez as its new CEO
area as the world recognises the growing threat of antimicrobial resistance.
More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Antibiotic resistance: The silent pandemic
Up to 2 billion people, mainly in low- and middle-income countries, lack access to antimicrobials. ... Available at: https://www.healtheuropa.eu/antimicrobial-resistance/88272/. Accessed November 2019. World Health Organization. WHO global strategy for
-
Mobilising the public to combat the antimicrobial resistance crisis
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. ... Her illness is due to antimicrobial resistance (AMR) and it is not as rare as you might think.
-
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating ... Antimicrobial resistance claims 5,
-
Antibiotic Resistance: Alarm bells ring louder than ever
where antibiotics and the threat of antimicrobial resistance (AMR) became a hot topic in the mainstream media. ... Another angle is the development of small molecules that can be administered in conjunction with antimicrobials to prevent resistance
-
Blue Latitude Health
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. ... Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Account Director
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Lead Copywriter
-
Competitive
-
Medical Editor
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- J&J could launch its single-dose COVID-19 vaccine in March
- J&J trims the size of its phase 3 COVID-19 vaccine trial
- Celltrion’s investigational mAb cuts COVID-19 recovery time
- Two drugs found to reduce mortality in severe COVID-19 patients
- Novavax moves closer toward launch of US phase 3 COVID-19 vaccine trial
- Pfizer/BioNTech to offer COVID-19 vaccine to placebo recipients
- Lucid Group bolster its talent with a further twelve new starters for 2021
- UK pharmacies to begin administering COVID-19 vaccinations
- PHE study finds people who have had COVID-19 can still transmit the virus
- New dosing option for AZ’s Imfinzi approved in the EU and UK
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- New executive appointments at Synergy Vision
PMHub
Viseven
Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...
Latest intelligence
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
- Delphi Technique Virtual Co-creation: A Customer Story
- How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
- Three ways AI will change healthcare in the next decade
- Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...
Quick links
Infographics
